Brett R Hagen Insider Profile
11 Followers
Brett R Hagen, CAO at Kalaris Therapeutics, holds 0.00 shares in Kalaris Therapeutics (Ticker: KLRS), holds ― shares in Kineta (Ticker: KANT). Most recently, Brett R Hagen Sold ― shares of Kalaris Therapeutics on Mar 23, 2026 for an estimated value of $12.87K.
Brett R Hagen's Trading History
| KLRSKalaris Therapeutics | Mar 23, 2026 | CAO | Informative Sell | 12.87K | $0.00 | |
| KANTKineta | ― | ― | ― | ― |
You May Also Like
Brett R Hagen insider profile FAQ
What is the percentage of profitable transactions made by Brett R Hagen?
The percentage of profitable transactions made by Brett R Hagen is 97%.
What is the average return per transaction made by Brett R Hagen?
The average return per transaction made by Brett R Hagen is 54.40%.
What stocks does Brett R Hagen hold?
Brett R Hagen holds: KLRS, KANT stocks.
What was Brett R Hagen’s latest transaction?
Brett R Hagen’s latest transaction was an Informative Sell of $12.87K.
What was Brett R Hagen's most profitable transaction?
Brett R Hagen’s most profitable transaction was an Informative Sell of KLRS stock on July 3, 2024. The return on the trade was 85.20%.
What is Brett R Hagen's role in Kalaris Therapeutics?
Brett R Hagen's role in Kalaris Therapeutics is CAO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.